These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 33735176)

  • 1. Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study.
    Gerardin M; Rousselet M; Couec ML; Masseau A; Guerlais M; Authier N; Deheul S; Roussin A; Micallef J; Djezzar S; ; Feuillet F; Jolliet P; Victorri-Vigneau C
    PLoS One; 2021; 16(3):e0248649. PubMed ID: 33735176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHEDRE trial protocol - observational study of the prevalence of problematic use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and analgesics in the French sickle-cell disease population.
    Gérardin M; Couec ML; Grall-Bronnec M; Feuillet F; Wainstein L; Rousselet M; Pinot ML; Perrouin F; Bonnot O; Drouineau MH; Jolliet P; Victorri-Vigneau C
    BMC Psychiatry; 2015 Nov; 15():281. PubMed ID: 26573686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance use disorder of equimolar oxygen-nitrous oxide mixture in French sickle-cell patients: results of the PHEDRE study.
    Gérardin M; Rousselet M; Couec ML; Masseau A; ; Aquizerate A; Authier N; Deheul S; Roussin A; Micallef J; Djezzar S; ; Feuillet F; Jolliet P; Grall-Bronnec M; Victorri-Vigneau C
    Orphanet J Rare Dis; 2024 Mar; 19(1):124. PubMed ID: 38500184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of opioid use in sickle cell disease.
    Han J; Zhou J; Saraf SL; Gordeuk VR; Calip GS
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):479-486. PubMed ID: 28815799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
    Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
    Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study.
    Rollé A; Vidal E; Laguette P; Garnier Y; Delta D; Martino F; Portecop P; Etienne-Julan M; Piednoir P; De Jong A; Romana M; Bernit E
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138299
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    Abrams DI; Couey P; Dixit N; Sagi V; Hagar W; Vichinsky E; Kelly ME; Connett JE; Gupta K
    JAMA Netw Open; 2020 Jul; 3(7):e2010874. PubMed ID: 32678452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily home opioid use in adults with sickle cell disease: The PiSCES project.
    Smith WR; McClish DK; Dahman BA; Levenson JL; Aisiku IP; de A Citero V; Bovbjerg VE; Roberts JD; Penberthy LT; Roseff SD
    J Opioid Manag; 2015; 11(3):243-53. PubMed ID: 25985809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden and quality of life of caregivers of patients with sickle cell disease in the United Kingdom and France: a cross-sectional study.
    Besser M; O'Sullivan SB; Bourke S; Longworth L; Barcelos GT; Oluboyede Y
    J Patient Rep Outcomes; 2024 Sep; 8(1):110. PubMed ID: 39325265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized Trial of Yoga for Children Hospitalized With Sickle Cell Vaso-Occlusive Crisis.
    Moody K; Abrahams B; Baker R; Santizo R; Manwani D; Carullo V; Eugenio D; Carroll A
    J Pain Symptom Manage; 2017 Jun; 53(6):1026-1034. PubMed ID: 28192225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    Casella JF; Barton BA; Kanter J; Black LV; Majumdar S; Inati A; Wali Y; Drachtman RA; Abboud MR; Kilinc Y; Fuh BR; Al-Khabori MK; Takemoto CM; Salman E; Sarnaik SA; Shah N; Morris CR; Keates-Baleeiro J; Raj A; Alvarez OA; Hsu LL; Thompson AA; Sisler IY; Pace BS; Noronha SA; Lasky JL; de Julian EC; Godder K; Thornburg CD; Kamberos NL; Nuss R; Marsh AM; Owen WC; Schaefer A; Tebbi CK; Chantrain CF; Cohen DE; Karakas Z; Piccone CM; George A; Fixler JM; Singleton TC; Moulton T; Quinn CT; de Castro Lobo CL; Almomen AM; Goyal-Khemka M; Maes P; Emanuele M; Gorney RT; Padgett CS; Parsley E; Kronsberg SS; Kato GJ; Gladwin MT
    JAMA; 2021 Apr; 325(15):1513-1523. PubMed ID: 33877274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.
    Dampier CD; Smith WR; Wager CG; Kim HY; Bell MC; Miller ST; Weiner DL; Minniti CP; Krishnamurti L; Ataga KI; Eckman JR; Hsu LL; McClish D; McKinlay SM; Molokie R; Osunkwo I; Smith-Whitley K; Telen MJ;
    Clin Trials; 2013 Apr; 10(2):319-31. PubMed ID: 23539110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management.
    Tanabe P; Hafner JW; Martinovich Z; Artz N
    Acad Emerg Med; 2012 Apr; 19(4):430-8. PubMed ID: 22506947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and disease burden of sickle cell disease in France: A descriptive study based on a French nationwide claim database.
    Leleu H; Arlet JB; Habibi A; Etienne-Julan M; Khellaf M; Adjibi Y; Pirenne F; Pitel M; Granghaud A; Sinniah C; De Montalembert M; Galacteros F
    PLoS One; 2021; 16(7):e0253986. PubMed ID: 34242255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation.
    Kato-Lin YC; Krishnamurti L; Padman R; Seltman HJ
    Int J Med Inform; 2014 Nov; 83(11):814-24. PubMed ID: 25179666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study.
    Sinha CB; Bakshi N; Ross D; Krishnamurti L
    JAMA Netw Open; 2019 May; 2(5):e194410. PubMed ID: 31125105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
    Osunkwo I; Andemariam B; Minniti CP; Inusa BPD; El Rassi F; Francis-Gibson B; Nero A; Trimnell C; Abboud MR; Arlet JB; Colombatti R; de Montalembert M; Jain S; Jastaniah W; Nur E; Pita M; DeBonnett L; Ramscar N; Bailey T; Rajkovic-Hooley O; James J
    Am J Hematol; 2021 Apr; 96(4):404-417. PubMed ID: 33264445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.